Hexter Joshua
Transaction: 07/02/2026
SELL
Change
-50,000
Price
$3.69
Filing
07/02/2026
Type
SELL
Oramed Pharmaceuticals Inc.
ORMP • Biotechnology
$5.01
▲ +0.08 (+1.62%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$212.93M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Stable or improving margins · 32.0%Reasonable earnings multiple · 1.84Manageable debt level · 0Healthy liquidity · 6.98Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:58 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$5.01
Change1.62%
Shares Out42.50M
Market Cap$212.93M
Enterprise Value$197.57M
52W Range1.98 - 5.19
Beta1.16
P/E1.07
P/B0.67
P/FCF-39.63
EV/EBITDA3.01
EV/FCF-36.77
Price$5.01
Change1.62%
Shares Out42.50M
Market Cap$212.93M
Enterprise Value$197.57M
52W Range1.98 - 5.19
Beta1.16
P/E1.07
P/B0.67
P/FCF-39.63
EV/EBITDA3.01
EV/FCF-36.77
Earnings Yield93.13%
FCF Yield-2.52%
Dividend Yield4.99%
Gross Margin0.65%
Oper. Margin-7.54%
Profit Margin32.02%
Debt/Eq0.00
Current Ratio6.98
Quick Ratio6.98
Volume151.92K
Avg Volume247.48K
EPS Surprise0.02
Investment DNA
How strong this company looks for long-term investors
52
out of 100
Business Quality
Margins, moat, returns
65/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
76/100
Why this score▼
Stable or improving margins · 32.0%Reasonable earnings multiple · 1.84Manageable debt level · 0Healthy liquidity · 6.98Negative growth trend
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
88/100
Bullish
Bullish
6
Hold
2
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 4 high-volume insider sells detected
Hexter Joshua
Transaction: 07/02/2026
BUY
Change
+50,000
Price
$3.69
Filing
07/02/2026
Type
BUY
Gabay Avraham
Transaction: 07/01/2026
SELL
Change
-73,360
Price
$4.51
Filing
07/02/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Hexter Joshua | SELL | -50,000 | $3.69 | 07/02/2026 | 07/02/2026 |
| Hexter Joshua | BUY | +50,000 | $3.69 | 07/02/2026 | 07/02/2026 |
| Gabay Avraham | SELL | -73,360 | $4.51 | 07/01/2026 | 07/02/2026 |
| Hexter Joshua | SELL | -137,000 | $4.46 | 07/01/2026 | 07/02/2026 |
| Kidron Miriam | SELL | -435,084 | $3.31 | 03/30/2026 | 03/31/2026 |
| KIDRON NADAV | SELL | -44,818 | $3.31 | 03/30/2026 | 03/31/2026 |
| Gabay Avraham | BUY | +95,889 | Not reported | 03/17/2026 | 03/18/2026 |
| Hexter Joshua | BUY | +95,889 | Not reported | 03/17/2026 | 03/18/2026 |
| KIDRON NADAV | BUY | +167,005 | Not reported | 03/17/2026 | 03/18/2026 |
| Kidron Miriam | BUY | +119,558 | Not reported | 03/17/2026 | 03/18/2026 |
| KIDRON NADAV | SELL | -100,000 | Not reported | 03/12/2026 | 03/16/2026 |
| KIDRON NADAV | SELL | -109,000 | Not reported | 01/22/2026 | 01/29/2026 |
| KIDRON NADAV | BUY | +109,000 | Not reported | 01/22/2026 | 01/29/2026 |
| Gabay Avraham | SELL | -19,000 | Not reported | 01/22/2026 | 01/29/2026 |
| Gabay Avraham | BUY | +19,000 | Not reported | 01/22/2026 | 01/29/2026 |
| Kidron Miriam | SELL | -19,000 | Not reported | 01/22/2026 | 01/29/2026 |
| Kidron Miriam | BUY | +19,000 | Not reported | 01/22/2026 | 01/29/2026 |
| Hexter Joshua | SELL | -19,000 | Not reported | 01/22/2026 | 01/29/2026 |
| Hexter Joshua | BUY | +19,000 | Not reported | 01/22/2026 | 01/29/2026 |
| Kidron Miriam | SELL | -86,166 | Not reported | 01/14/2026 | 01/21/2026 |